Table 2. General linear model analysis for repeated measurements.

	ESWT (n=32)	Injection (n=28)
Treatment	Mean±SD	Mean±SD	f	p
VAS-before treatment (cm)	6.84±0.95	6.96±0.99
VAS-3rd week (cm)	1.09±0.96	0.78±0.73	1399.5* 0.789**	0.001* 0.378**
VAS-3rd month (cm)	1.03±1.03	0.78±0.83
Trochanteric tenderness-before treatment (cm)	6.84±1.01	7.00±1.05
Trochanteric tenderness-3rd week (cm)	1.18±1.06	0.78±0.73	982.5* 1.711**	0.001* 0.185**
Trochanteric tenderness-3rd month (cm)	1.03±0.99	0.78±0.73
WOMAC-before treatment	47.00±8.80	46.78±9.56
WOMAC-3rd week	7.59±7.59	5.10±3.83	1.580* 1.153**	0.001* 0.287**
WOMAC-3rd month	6.73±6.54	4.27±4.35
SF-36 Physical function before treatment	58.90±13.42	58.75±11.98	1.537*	0.001*
SF-36 Physical function-3rd month	70.90±13.42	70.75±11.98	0.002**	0.962**
SF-36 Physical role difficulty before treatment	36.71±16.78	36.60±14.40	402.1*	0.001*
SF-36 Physical role difficulty -3rd month	43.81±16.90	45.42±14.67	0.34**	0.853**
SF-36 Emotional role limitation-before treatment	58.50±19.67	59.22±19.83	43.81*	0.069*
SF-36 Emotional role limitation-3rd month	59.21±18.60	60.92±18.24	0.62**	0.805**
SF-36 Energy-before treatment	59.06±15.78	54.82±12.58	1.495*	0.226*
SF-36 Energy-3rd month	61.25±13.55	57.32±10.49	0.32**	0.859**
SF-36 Mental Health-before treatment	63.84±13.72	64.28±11.77	0.12*	0.687*
SF-36 Mental Health-3rd month	63.96±14.18	64.35±11.93	0.15**	0.902**
SF-36 Social function-before treatment	53.64±15.80	56.62±12.64	1.19*	0.279*
SF-36 Social function-3td month	59.89±13.09	60.91±10.24	0.369**	0.546**
SF-36 Pain-before treatment	46.18±11.06	45.75±12.40	25.21*	0,001*
SF-36 Pain-3rd month	53.34±10.77	49.64±9.40	0.626**	0.432**
General health-before treatment (cm)	55.93±15.26	56.07±13.28	0.77*	0.783*
General health-3rd month	56.28±14.76	56.03±12.50	1.153**	0.287**
SD: Standard deviation; VAS: Visual Analog Scale; WOMAC: Western Ontario and McMaster University Osteoarthritis Index; SF-36: Short Form Health Survey; * Change over time; ** Difference between groups.